Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SARL RUAN BIO : revenue, balance sheet and financial ratios

SARL RUAN BIO is a French company founded 9 years ago, specialized in the sector Supérettes. Based in JANZE (35150), this company of category PME shows in 2022 a net income positive of 45 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-02

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SARL RUAN BIO (SIREN 824790026)
Indicator 2022 2021 2020 2019 2018
Revenue N/C N/C N/C N/C N/C
Net income 45 047 € 80 390 € 46 430 € 32 871 € -38 369 €
EBITDA N/C N/C N/C N/C N/C
Net margin N/C N/C N/C N/C N/C

Revenue and income statement

In 2022, SARL RUAN BIO generates positive net income of 45 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.

Net income (2022) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

45 047 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 88%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 37%. The balance between equity and debt is satisfactory.

Debt ratio (2022) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

87.863%

Financial autonomy (2022) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

37.49%

Asset age ratio (2022) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

31.0%

Solvency indicators evolution
SARL RUAN BIO

Sector positioning

Debt ratio
87.86 2022
2020
2021
2022
Q1: 0.27
Med: 35.38
Q3: 115.7
Average -9 pts over 3 years

In 2022, the debt ratio of SARL RUAN BIO (87.86) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
37.49% 2022
2020
2021
2022
Q1: 10.63%
Med: 32.48%
Q3: 52.48%
Good +29 pts over 3 years

In 2022, the financial autonomy of SARL RUAN BIO (37.5%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 226.06. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2022) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

226.062

Liquidity indicators evolution
SARL RUAN BIO

Sector positioning

Liquidity ratio
226.06 2022
2020
2021
2022
Q1: 95.36
Med: 147.0
Q3: 226.02
Excellent +8 pts over 3 years

In 2022, the liquidity ratio of SARL RUAN BIO (226.06) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Positioning of SARL RUAN BIO in its sector

Comparison with sector Supérettes

Valuation estimate

Based on 265 transactions of similar company sales in 2022, the value of SARL RUAN BIO is estimated at 365 025 € (range 144 099€ - 803 624€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2022
265 transactions
144k€ 365k€ 803k€
365 025 € Range: 144 099€ - 803 624€
NAF 5 année 2022

Valuation method used

Net Income Multiple
45 047 € × 8.1x = 365 026 €
Range: 144 100€ - 803 625€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 265 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Supérettes)

Compare SARL RUAN BIO with other companies in the same sector:

Frequently asked questions about SARL RUAN BIO

What is the revenue of SARL RUAN BIO ?

The revenue of SARL RUAN BIO is not publicly disclosed (confidential accounts filed with INPI).

Is SARL RUAN BIO profitable?

Yes, SARL RUAN BIO generated a net profit of 45 k€ in 2022.

Where is the headquarters of SARL RUAN BIO ?

The headquarters of SARL RUAN BIO is located in JANZE (35150), in the department Ille-et-Vilaine.

Where to find the tax return of SARL RUAN BIO ?

The tax return of SARL RUAN BIO is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SARL RUAN BIO operate?

SARL RUAN BIO operates in the sector Supérettes (NAF code 47.11C). See the 'Sector positioning' section above to compare the company with its competitors.